124 related articles for article (PubMed ID: 38238904)
1. MEK1/2-PKM2 Pathway Modulates the Immunometabolic Reprogramming of Proinflammatory Allograft-infiltrating Macrophages During Heart Transplant Rejection.
Chen Z; Li Y; Niu Y; Zhang X; Yu J; Cui J; Ran S; Wang S; Ye W; Xia J; Wu J
Transplantation; 2024 May; 108(5):1127-1141. PubMed ID: 38238904
[TBL] [Abstract][Full Text] [Related]
2. Metabolic and Proliferative State of Vascular Adventitial Fibroblasts in Pulmonary Hypertension Is Regulated Through a MicroRNA-124/PTBP1 (Polypyrimidine Tract Binding Protein 1)/Pyruvate Kinase Muscle Axis.
Zhang H; Wang D; Li M; Plecitá-Hlavatá L; D'Alessandro A; Tauber J; Riddle S; Kumar S; Flockton A; McKeon BA; Frid MG; Reisz JA; Caruso P; El Kasmi KC; Ježek P; Morrell NW; Hu CJ; Stenmark KR
Circulation; 2017 Dec; 136(25):2468-2485. PubMed ID: 28972001
[TBL] [Abstract][Full Text] [Related]
3. PKM2-dependent glycolysis promotes NLRP3 and AIM2 inflammasome activation.
Xie M; Yu Y; Kang R; Zhu S; Yang L; Zeng L; Sun X; Yang M; Billiar TR; Wang H; Cao L; Jiang J; Tang D
Nat Commun; 2016 Oct; 7():13280. PubMed ID: 27779186
[TBL] [Abstract][Full Text] [Related]
4. Fibrinogen-like protein 2 regulates macrophage glycolytic reprogramming by directly targeting PKM2 and exacerbates alcoholic liver injury.
Hu X; Wan X; Diao Y; Shen Z; Zhang Z; Wang P; Hu D; Wang X; Yan W; Yu C; Luo X; Wang H; Ning Q
Int Immunopharmacol; 2023 Nov; 124(Pt B):110957. PubMed ID: 37734200
[TBL] [Abstract][Full Text] [Related]
5. Macrophage subpopulations and their impact on chronic allograft rejection versus graft acceptance in a mouse heart transplant model.
Zhao Y; Chen S; Lan P; Wu C; Dou Y; Xiao X; Zhang Z; Minze L; He X; Chen W; Li XC
Am J Transplant; 2018 Mar; 18(3):604-616. PubMed ID: 29044999
[TBL] [Abstract][Full Text] [Related]
6. Transcription factor LHX9 (LIM Homeobox 9) enhances pyruvate kinase PKM2 activity to induce glycolytic metabolic reprogramming in cancer stem cells, promoting gastric cancer progression.
Zhao H; Jiang R; Feng Z; Wang X; Zhang C
J Transl Med; 2023 Nov; 21(1):833. PubMed ID: 37980488
[TBL] [Abstract][Full Text] [Related]
7. Graft IL-33 regulates infiltrating macrophages to protect against chronic rejection.
Li T; Zhang Z; Bartolacci JG; Dwyer GK; Liu Q; Mathews LR; Velayutham M; Roessing AS; Lee YC; Dai H; Shiva S; Oberbarnscheidt MH; Dziki JL; Mullet SJ; Wendell SG; Wilkinson JD; Webber SA; Wood-Trageser M; Watkins SC; Demetris AJ; Hussey GS; Badylak SF; Turnquist HR
J Clin Invest; 2020 Oct; 130(10):5397-5412. PubMed ID: 32644975
[TBL] [Abstract][Full Text] [Related]
8. Myeloid Cell PKM2 Deletion Enhances Efferocytosis and Reduces Atherosclerosis.
Doddapattar P; Dev R; Ghatge M; Patel RB; Jain M; Dhanesha N; Lentz SR; Chauhan AK
Circ Res; 2022 Apr; 130(9):1289-1305. PubMed ID: 35400205
[TBL] [Abstract][Full Text] [Related]
9. PKM2-dependent metabolic reprogramming in CD4
Lü S; Deng J; Liu H; Liu B; Yang J; Miao Y; Li J; Wang N; Jiang C; Xu Q; Wang X; Feng J
J Mol Med (Berl); 2018 Jun; 96(6):585-600. PubMed ID: 29732501
[TBL] [Abstract][Full Text] [Related]
10. MEK1/2 Inhibitors Unlock the Constrained Interferon Response in Macrophages Through IRF1 Signaling.
Yang L; Ding JL
Front Immunol; 2019; 10():2020. PubMed ID: 31507609
[TBL] [Abstract][Full Text] [Related]
11. Glutathione-S-transferase P promotes glycolysis in asthma in association with oxidation of pyruvate kinase M2.
van de Wetering C; Manuel AM; Sharafi M; Aboushousha R; Qian X; Erickson C; MacPherson M; Chan G; Adcock IM; ZounematKermani N; Schleich F; Louis R; Bohrnsen E; D'Alessandro A; Wouters EF; Reynaert NL; Li J; Wolf CR; Henderson CJ; Lundblad LKA; Poynter ME; Dixon AE; Irvin CG; van der Vliet A; van der Velden JL; Janssen-Heininger YM
Redox Biol; 2021 Nov; 47():102160. PubMed ID: 34624602
[TBL] [Abstract][Full Text] [Related]
12. Analysis of macrophage phenotype in rejected corneal allografts.
Oh JY; Lee HJ; Ko AY; Ko JH; Kim MK; Wee WR
Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7779-84. PubMed ID: 24159090
[TBL] [Abstract][Full Text] [Related]
13. Pyruvate kinase M2 regulates Hif-1α activity and IL-1β induction and is a critical determinant of the warburg effect in LPS-activated macrophages.
Palsson-McDermott EM; Curtis AM; Goel G; Lauterbach MA; Sheedy FJ; Gleeson LE; van den Bosch MW; Quinn SR; Domingo-Fernandez R; Johnston DG; Jiang JK; Israelsen WJ; Keane J; Thomas C; Clish C; Vander Heiden M; Xavier RJ; O'Neill LA
Cell Metab; 2015 Jan; 21(1):65-80. PubMed ID: 25565206
[TBL] [Abstract][Full Text] [Related]
14. Graft-Infiltrating Macrophages Adopt an M2 Phenotype and Are Inhibited by Purinergic Receptor P2X7 Antagonist in Chronic Rejection.
Wu C; Zhao Y; Xiao X; Fan Y; Kloc M; Liu W; Ghobrial RM; Lan P; He X; Li XC
Am J Transplant; 2016 Sep; 16(9):2563-73. PubMed ID: 27575724
[TBL] [Abstract][Full Text] [Related]
15. Smooth Muscle Cell-Specific PKM2 (Pyruvate Kinase Muscle 2) Promotes Smooth Muscle Cell Phenotypic Switching and Neointimal Hyperplasia.
Jain M; Dhanesha N; Doddapattar P; Nayak MK; Guo L; Cornelissen A; Lentz SR; Finn AV; Chauhan AK
Arterioscler Thromb Vasc Biol; 2021 May; 41(5):1724-1737. PubMed ID: 33691477
[TBL] [Abstract][Full Text] [Related]
16. Bile acids attenuate PKM2 pathway activation in proinflammatory microglia.
Romero-Ramírez L; García-Rama C; Wu S; Mey J
Sci Rep; 2022 Jan; 12(1):1459. PubMed ID: 35087114
[TBL] [Abstract][Full Text] [Related]
17. Immune Regulation of the Liver Through the PCSK9/CD36 Pathway During Heart Transplant Rejection.
Zhang X; Xu H; Yu J; Cui J; Chen Z; Li Y; Niu Y; Wang S; Ran S; Zou Y; Wu J; Xia J
Circulation; 2023 Jul; 148(4):336-353. PubMed ID: 37232170
[TBL] [Abstract][Full Text] [Related]
18. Deoxyelephantopin decreases the release of inflammatory cytokines in macrophage associated with attenuation of aerobic glycolysis via modulation of PKM2.
Pan L; Hu L; Zhang L; Xu H; Chen Y; Bian Q; Zhu A; Wu H
Int Immunopharmacol; 2020 Feb; 79():106048. PubMed ID: 31863924
[TBL] [Abstract][Full Text] [Related]
19. FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2.
Rao J; Wang H; Ni M; Wang Z; Wang Z; Wei S; Liu M; Wang P; Qiu J; Zhang L; Wu C; Shen H; Wang X; Cheng F; Lu L
Gut; 2022 Dec; 71(12):2539-2550. PubMed ID: 35140065
[TBL] [Abstract][Full Text] [Related]
20. HSPA12A Is a Novel Player in Nonalcoholic Steatohepatitis via Promoting Nuclear PKM2-Mediated M1 Macrophage Polarization.
Kong Q; Li N; Cheng H; Zhang X; Cao X; Qi T; Dai L; Zhang Z; Chen X; Li C; Li Y; Xue B; Fang L; Liu L; Ding Z
Diabetes; 2019 Feb; 68(2):361-376. PubMed ID: 30455376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
